NCT02676440

Brief Summary

This study is a double-blind, randomised, parallel group efficacy study. Up to 240 healthy female and male participants aged over 18 years will participate. There will be two groups of up to 120 participants. Participants will be randomised to the test groups according the allocation table prepared by the Statistician. Participants will be enrolled on to the study according to the inclusion/exclusion criteria. After enrollment participants will have their teeth that have been allocated for assessment cleaned using a professional prophylaxis polish by the study dentist. The participants will then be provided with a standard cosmetic silica Fluoride toothpaste and a toothbrush to use at home, twice a day for up to four weeks. After this time they will return to the test site and have the baseline dental assessments. Participants will then be randomly allocated to one of the two test products which they will use at home, twice a day for the duration of the study. Dental assessments will be conducted after 13 and 26 weeks of product use at the study site.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
222

participants targeted

Target at P75+ for not_applicable healthy

Timeline
Completed

Started Jul 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 3, 2015

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

December 3, 2015

Completed
11 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 14, 2015

Completed
2 months until next milestone

First Posted

Study publicly available on registry

February 8, 2016

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

March 14, 2016

Completed
Last Updated

June 8, 2018

Status Verified

June 1, 2018

Enrollment Period

5 months

First QC Date

December 3, 2015

Last Update Submit

June 6, 2018

Conditions

Keywords

Oral Health

Outcome Measures

Primary Outcomes (3)

  • Change in gingival condition as assessed using the Modified Lobene Gingival Index

    13 weeks

  • Change in gingival condition as assessed using the Saxton and van der Ouderaa bleeding index

    13 weeks

  • Change in gingival condition as assessed using the Modified Quigley and Hein plaque index

    13 weeks

Secondary Outcomes (3)

  • Change in gingival condition as assessed using the Modified Lobene Gingival Index

    26 weeks

  • Change in gingival condition as assessed using the Saxton and van der Ouderaa bleeding index

    26 weeks

  • Change in gingival condition as assessed using the Modified Quigley and Hein plaque index

    26 weeks

Study Arms (2)

Treatment

OTHER

Toothpaste containing 1.11% Fluoride as Sodium Monofluorophosphate and Zinc Citrate Trihydrate Serum containing 0.17% Fluoride as Sodium Monofluorophosphate and Zinc Sulphate Heptahydrate

Other: Treatment

Comparator

OTHER

Silica toothpaste 1350ppm F as Sodium Fluoride

Other: Comparator

Interventions

F13/T38

Treatment

M26

Comparator

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Be aged 18 years and over, of either gender and in good health.
  • Be willing and physically able to carry out all study procedures.
  • Be willing and competent (verbally and cognitively) to give written informed consent and complete a medical history form.
  • Have at least 20 natural teeth including 5 teeth (excluding 3rd molars) in each quadrant
  • Have at least 6 natural teeth assessable teeth in the Upper 4 to 4 region.
  • Have a mean Modified Gingival Index (MGI) score of 2 at screening in the Upper 4 to 4 region.
  • Not have had a scale and prophylaxis in the month prior to enrolment or have one scheduled prior to the end of the study.
  • Be willing to use the test products for 6 months

You may not qualify if:

  • Current participation in any other cosmetic trials, any dental clinical trials or clinical trials.
  • Pregnant or nursing women.
  • Medical condition and/or regular use of any medication which might affect the outcome of the study, as determined by the study dentist, principally a course of anti-inflammatory, antimicrobial or statin drugs
  • Obvious signs of untreated caries or significant periodontal disease, which in the opinion of the Study Dentist, will affect either the scientific validity of the study or if the participants was to participate in the study would affect their wellbeing.
  • Any participant who, in the judgement of the investigator, should not participate in the study.
  • Full or partial dentures wearers.
  • Current orthodontic treatment.
  • Have oral piercings.
  • Smokers or those who have a recent smoking history.
  • Taking dietary supplements (e.g. multivitamins; antioxidants; fish oils).
  • Any subject with a single MGI score of 4 in the any area of the mouth at any time point will be excluded.
  • A subject will be excluded from the study if they have a MGI mouth mean of \>2.75 at screening
  • Any subject with a single MGI score of 3 at Baseline
  • Use of non study oral care products, e.g. dental floss, chewing gum, mouth rinses during the pre treatment and test phases of the study.
  • The subject is an employee of Unilever or a member of the study team.
  • +3 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bristol Dental Hospital and School

Bristol, BS1 2LY, United Kingdom

Location

MeSH Terms

Interventions

Therapeutics

Study Officials

  • Nicola X West, BDS

    Bristol Dental Hospital and School

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 3, 2015

First Posted

February 8, 2016

Study Start

July 3, 2015

Primary Completion

December 14, 2015

Study Completion

March 14, 2016

Last Updated

June 8, 2018

Record last verified: 2018-06

Locations